FAQ on whether a medical device registration pathway can be reused across multiple countries, what parts of the dossier are reusable, what must be localized, and AIMEILI's planning recommendations.
Answer: Yes. When the same product enters multiple countries, the registration dossier can be partially reused, but it cannot simply be copied. Product descriptions, technical specifications, risk management, test reports, clinical evaluations, ISO 13485 certificates, and core technical files generally have reuse value. However, different countries have different requirements for local agents/authorized representatives, label language, authorization documents, notarization and legalization, official forms, UDI, product classification, and depth of review. A more reliable approach is to first establish a high-quality core technical file, and then localize it item by item according to each target country.
Prepared by the AIMEILI Regulatory Editorial Team based on public regulatory materials, registration practice, and the medical device international registration knowledge base.
Published: 2026-07-08 09:00 | Updated: 2026-07-08 09:00
This article organizes the issues that companies need to prioritize in actual projects around international medical device registration, dossier preparation, compliance pathways, and post-market maintenance.
Content Structure
- Key Summary
- Decision Logic
- Dossier Priorities
- Common Misconceptions
- AIMEILI View
- Continue Reading
- Applicability Boundaries
Key Summary
When the same product enters multiple countries, the registration dossier can be partially reused, but it cannot simply be copied. Product descriptions, technical specifications, risk management, test reports, clinical evaluations, ISO 13485 certificates, and core technical files generally have reuse value. However, different countries have different requirements for local agents/authorized representatives, label language, authorization documents, notarization and legalization, official forms, UDI, product classification, and depth of review. A more reliable approach is to first establish a high-quality core technical file, and then localize it item by item according to each target country.
Decision Logic
Companies should first evaluate target markets, registration pathways, commercial launch plans, and the current status of dossiers in a single table. Without an upfront pathway assessment, companies may face repeated rework on local representation, labeling, testing, clinical evidence, or certificate maintenance.
Dossier Priorities
When preparing dossiers, companies should focus on checking whether the product description, intended use, model specifications, risk management, performance verification, clinical or evaluation evidence, labels and instructions for use, quality system certification, authorization documents, and post-market maintenance arrangements are mutually consistent.
Common Misconceptions
A common misconception is treating the local agent as an ordinary commercial contact and overlooking its responsibilities for receiving regulatory notifications, maintaining certificates, supporting adverse event reporting, and handing over dossiers. Unclear agent arrangements may later affect channel changes and market control.
AIMEILI View
AIMEILI recommends that companies evaluate this issue during project initiation rather than handling it ad hoc before submission. A more reliable approach is to first complete product classification, dossier gap analysis, target country prioritization, local responsible entity determination, and post-market maintenance arrangements, and then form an executable registration plan.
Continue Reading
Previous: Where Does Medical Device Export Registration Usually Begin?
Next: Should We Complete Country Registration First or Find a Local Distributor First?
Recommended Reading
- How Should the Medical Device Registration Dossier Checklist for Indonesia Be Prepared?
- How Is the Singapore HSA Medical Device Registration Process Conducted?
- What Documents Are Required for Medical Device Import Registration in Vietnam?
- How Should a Local Agent for Medical Device Registration in the Middle East Be Selected?
- Medical Device Registration Dossier Checklist for Malaysia MDA?
- Medical Device Registration Dossier Checklist for Saudi SFDA?
Return to FAQ Center | News and Insights | Contact AIMEILI
Content Review and Applicability Boundaries
Content Author: AIMEILI Regulatory Editorial Team
Professional Review: AIMEILI Medical Device International Registration Project Team
Source Principles: Priority is given to official regulatory agencies, international organizations, standards organizations, and publicly available regulatory materials; industry media and project experience are used only as auxiliary references for judgment.
Applicability Boundaries: This article is intended for preliminary understanding, dossier preparation, and project planning. It does not replace the formal requirements of the target country regulatory authority, testing conclusions, or legal opinions.
Need a registration pathway assessment?
Send product type, intended use, target countries and existing certificates. AIMEILI can help evaluate registration pathway, documentation gaps and compliance risks.
Contact AIMEILI